Cargando…
Sox2 is required for tumor development and cancer cells proliferation in osteosarcoma
The stem cell transcription factor Sox2 is highly expressed in many cancers where it is thought to mark cancer stem cells (CSC). In osteosarcomas, the most common bone malignancy, high Sox2 expression marks and maintains a fraction of tumor initiating cells that show all the properties of CSC. Knock...
Autores principales: | Maurizi, Giulia, Verma, Narendra, Gadi, Abhilash, Mansukhani, Alka, Basilico, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195857/ https://www.ncbi.nlm.nih.gov/pubmed/29743593 http://dx.doi.org/10.1038/s41388-018-0292-2 |
Ejemplares similares
-
Sox2 maintains self-renewal of tumor initiating cells in osteosarcomas
por: Basu-Roy, Upal, et al.
Publicado: (2011) -
The transcription factor Sox2 is required for osteoblast self-renewal
por: Basu-Roy, Upal, et al.
Publicado: (2010) -
PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity
por: Basu-Roy, Upal, et al.
Publicado: (2016) -
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation
por: Mansukhani, Alka, et al.
Publicado: (2005) -
Signaling by Fibroblast Growth Factors (Fgf) and Fibroblast Growth Factor Receptor 2 (Fgfr2)–Activating Mutations Blocks Mineralization and Induces Apoptosis in Osteoblasts
por: Mansukhani, Alka, et al.
Publicado: (2000)